List of Studies ( Metabolite:2-Methylglutaconic acid)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST002371 | AN003866 | High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages | Macrophages | Mouse | Inflammation | Wake Forest School of Medicine | GC-MS |
| ST002152 | AN003524 | Metabolomics analysis of mouse liver with or without SIRT5 deficiency | Liver | Mouse | North Carolina State University | LC-MS | |
| ST002119 | AN003468 | Metabolomics analysis of zebrafish response to CID661578 treatment | Larvae | Zebrafish | Diabetes | North Carolina State University | LC-MS |
| ST001611 | AN002646 | Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment | Muscle | Mouse | Cancer | North Carolina State University | LC-MS |
| ST001611 | AN002646 | Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment | Sarcoma | Mouse | Cancer | North Carolina State University | LC-MS |
| ST001441 | AN002408 | Metabolomics of patient-derived fibroblasts | Fibroblast cells | Human | Mitochondrial disease | North Carolina State University | LC-MS |
| ST000566 | AN000870 | Large Scale C18 Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function | Blood | Human | Heart disease | Mayo Clinic | LC-MS |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000665 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000045 | AN000072 | Plasma metabolomics: Comparison of non-diabetic controls with T1D patients | Blood | Human | Mayo Clinic | LC-MS | |
| ST000045 | AN000075 | Plasma metabolomics: Comparison of non-diabetic controls with T1D patients | Blood | Human | Mayo Clinic | LC-MS |
